Carl Hull, Maravai LifeSciences CEO

As pock­ets fill with cash, Mar­a­vai spends $240M to en­sure pure mR­NA pro­duc­tion

A San Diego-based life sci­ences com­pa­ny is tak­ing over a long­time sup­pli­er and Cal­i­for­nia neigh­bor to boost the pu­ri­ty of its nu­cleotides and im­prove the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.